Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1132)
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,475
Price
$1.88
Total Value
$6.54K
Shares Held After
95,461
% of Holdings
3.5%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
10,000
Price
$54.80
Total Value
$548.00K
Shares Held After
0
% of Holdings
100.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2,095
Price
$1.52
Total Value
$3.18K
Shares Held After
63,176
% of Holdings
3.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
20,753
Price
$1.52
Total Value
$31.54K
Shares Held After
625,766
% of Holdings
3.3%
Janux Therapeutics, Inc. (JANX)
Doyle Janeen Noel — Chief Corp. & Bus. Dev. Ofcr
Shares
4,059
Price
$14.03
Total Value
$56.94K
Shares Held After
75,941
% of Holdings
5.1%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
4,375
Price
$35.00
Total Value
$153.12K
Shares Held After
75,753
% of Holdings
5.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$70.60
Total Value
$1.41M
Shares Held After
3,985
% of Holdings
83.4%
Nautilus Biotechnology, Inc. (NAUT)
AH Equity Partners Bio II, L.L.C. — 10% Owner
Shares
384,026
Price
$2.35
Total Value
$902.46K
Shares Held After
971,885
% of Holdings
28.3%
Nautilus Biotechnology, Inc. (NAUT)
AH Equity Partners Bio II, L.L.C. — 10% Owner
Shares
4,615,974
Price
$2.35
Total Value
$10.85M
Shares Held After
11,682,032
% of Holdings
28.3%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.68
Total Value
$110.40K
Shares Held After
6,169,863
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,400
Price
$66.75
Total Value
$226.93K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
16,600
Price
$66.31
Total Value
$1.10M
Shares Held After
771,180
% of Holdings
2.1%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
78,416
% of Holdings
5.8%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
76,039
% of Holdings
6.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,595
Price
$0.45
Total Value
$13.32K
Shares Held After
512,525
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$543.26
Total Value
$152.11K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$541.68
Total Value
$238.34K
Shares Held After
40,793
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$540.48
Total Value
$346.45K
Shares Held After
41,233
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,310
Price
$539.83
Total Value
$1.25M
Shares Held After
41,874
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$538.81
Total Value
$619.09K
Shares Held After
44,184
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$537.62
Total Value
$787.08K
Shares Held After
45,333
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,056
Price
$536.62
Total Value
$1.10M
Shares Held After
46,797
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$535.69
Total Value
$621.40K
Shares Held After
48,853
% of Holdings
2.3%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
29,000
Price
$0.83
Total Value
$24.15K
Shares Held After
66,167
% of Holdings
43.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
4,500
Price
$7.33
Total Value
$33.00K
Shares Held After
66,300
% of Holdings
6.8%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO & Chief Business Officer
Shares
19,360
Price
$1.97
Total Value
$38.22K
Shares Held After
379,900
% of Holdings
4.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,709
Price
$1.97
Total Value
$11.27K
Shares Held After
98,936
% of Holdings
5.5%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
87,216
Price
$1.97
Total Value
$172.19K
Shares Held After
2,367,206
% of Holdings
3.6%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
5,000
Price
$56.00
Total Value
$280.00K
Shares Held After
10,000
% of Holdings
33.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$9.43
Total Value
$471.30K
Shares Held After
886,000
% of Holdings
5.6%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
206,005
Price
$15.28
Total Value
$3.15M
Shares Held After
13,044,106
% of Holdings
1.6%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
349
Price
$4.46
Total Value
$1.56K
Shares Held After
181,509
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.60
Total Value
$135.25K
Shares Held After
13,579
% of Holdings
37.5%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
5,537
Price
$223.39
Total Value
$1.24M
Shares Held After
29,603
% of Holdings
15.8%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.68
Total Value
$1.84K
Shares Held After
1,385,676
% of Holdings
0.0%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.64
Total Value
$1.82K
Shares Held After
1,385,176
% of Holdings
0.0%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
100
Price
$219.00
Total Value
$21.90K
Shares Held After
4,367
% of Holdings
2.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,498
Price
$1.55
Total Value
$2.32K
Shares Held After
61,081
% of Holdings
2.5%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
14,838
Price
$1.55
Total Value
$23.00K
Shares Held After
605,013
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,294
Price
$71.38
Total Value
$235.13K
Shares Held After
597,540
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,149
Price
$70.50
Total Value
$574.50K
Shares Held After
600,834
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,557
Price
$69.40
Total Value
$246.86K
Shares Held After
608,983
% of Holdings
0.6%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
3,100
Price
$72.06
Total Value
$223.39K
Shares Held After
97,994
% of Holdings
3.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,599
Price
$70.77
Total Value
$183.93K
Shares Held After
101,094
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,801
Price
$69.75
Total Value
$125.62K
Shares Held After
103,693
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,401
Price
$68.35
Total Value
$369.14K
Shares Held After
767,780
% of Holdings
0.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
12,989
Price
$67.41
Total Value
$875.59K
Shares Held After
773,181
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,610
Price
$66.39
Total Value
$106.88K
Shares Held After
786,170
% of Holdings
0.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
12,000
Price
$9.24
Total Value
$110.88K
Shares Held After
180,962
% of Holdings
6.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
828
Price
$439.91
Total Value
$364.25K
Shares Held After
19,959
% of Holdings
4.0%
Showing 751–800 of 1132 transactions (page 16 of 23)